RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer. The U.S. Food and Drug Administration (FDA) approved Genentechâs Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC).
The BCR-ABL tyrosine kinase inhibitor (TKI) GleevecÂ® is FDA approved for adults with Ph positive CML in blast crisis phase, accelerated phase, or in chronic phase after failure of interferon alpha therapy. Other drug choices include Sprycel, Tasigna, Bosulif and Synribo. A clinical trial is another treatment choice.